These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 32748626)
1. Prescribing Practices of Valproic Acid for Agitation and Delirium in the Intensive Care Unit. Quinn NJ; Hohlfelder B; Wanek MR; Duggal A; Torbic H Ann Pharmacother; 2021 Mar; 55(3):311-317. PubMed ID: 32748626 [TBL] [Abstract][Full Text] [Related]
2. Valproic Acid for the Management of Agitation and Delirium in the Intensive Care Setting: A Retrospective Analysis. Crowley KE; Urben L; Hacobian G; Geiger KL Clin Ther; 2020 Apr; 42(4):e65-e73. PubMed ID: 32273047 [TBL] [Abstract][Full Text] [Related]
3. Use of Valproic Acid for the Management of Delirium and Agitation in the Intensive Care Unit. Swayngim R; Preslaski C; Dawson J J Pharm Pract; 2024 Feb; 37(1):118-122. PubMed ID: 36154329 [No Abstract] [Full Text] [Related]
4. Valproate for agitation in critically ill patients: A retrospective study. Gagnon DJ; Fontaine GV; Smith KE; Riker RR; Miller RR; Lerwick PA; Lucas FL; Dziodzio JT; Sihler KC; Fraser GL J Crit Care; 2017 Feb; 37():119-125. PubMed ID: 27693975 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic Management of Intensive Care Unit Delirium: Clinical Prescribing Practices and Outcomes in More Than 8500 Patient Encounters. Boncyk CS; Farrin E; Stollings JL; Rumbaugh K; Wilson JE; Marshall M; Feng X; Shotwell MS; Pandharipande PP; Hughes CG Anesth Analg; 2021 Sep; 133(3):713-722. PubMed ID: 33433117 [TBL] [Abstract][Full Text] [Related]
6. Prolonged Refractory ICU Delirium Successfully Treated With Valproic Acid: Case Report and Literature Review. Subedi B; Louzon PR; Masood A; Recksieck S J Pharm Pract; 2021 Dec; 34(6):984-987. PubMed ID: 32912027 [TBL] [Abstract][Full Text] [Related]
7. Oral Agents for the Management of Agitation and Agitated Delirium in Critically Ill Patients. Yeo QM; Wiley TL; Smith MN; Hammond DA Crit Care Nurs Q; 2017; 40(4):344-362. PubMed ID: 28834857 [TBL] [Abstract][Full Text] [Related]
8. Impact of Early Reinitiation of Neuropsychiatric Medications on Agitation and Delirium in the Intensive Care Unit: A Retrospective Study. Cucci MD; Cunningham BS; Patel JS; Shimer AT; Mofleh DI; Mullen CL Ann Pharmacother; 2021 Jan; 55(1):15-24. PubMed ID: 32567359 [TBL] [Abstract][Full Text] [Related]
9. Valproic Acid in the Management of Delirium. Cuartas CF; Davis M Am J Hosp Palliat Care; 2022 May; 39(5):562-569. PubMed ID: 34409869 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases. Bourgeois JA; Koike AK; Simmons JE; Telles S; Eggleston C J Neuropsychiatry Clin Neurosci; 2005; 17(2):232-8. PubMed ID: 15939979 [TBL] [Abstract][Full Text] [Related]
11. Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults. White G; Adessky N; Chen FW; Regazzoni A; Tourian L; Chagnon M; Gursahaney A; Alharbi M; Williamson D; Perreault MM Int J Clin Pharm; 2024 Feb; 46(1):177-185. PubMed ID: 38071694 [TBL] [Abstract][Full Text] [Related]
12. Occurrence and Practices for Pain, Agitation, and Delirium in Intensive Care Unit Patients. Arroyo-Novoa CM; Figueroa-Ramos MI; Puntillo KA P R Health Sci J; 2019 Sep; 38(3):156-162. PubMed ID: 31536628 [TBL] [Abstract][Full Text] [Related]
13. Safety and Effectiveness of Intravenous Chlorpromazine for Agitation in Critically Ill Patients. Choi M; Barra ME; Newman K; Sin JH J Intensive Care Med; 2020 Oct; 35(10):1118-1122. PubMed ID: 30558470 [TBL] [Abstract][Full Text] [Related]
14. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit. Schildmann E; Pörnbacher S; Kalies H; Bausewein C Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260 [TBL] [Abstract][Full Text] [Related]
15. Implementation of a protocol for integrated management of pain, agitation, and delirium can improve clinical outcomes in the intensive care unit: a randomized clinical trial. Mansouri P; Javadpour S; Zand F; Ghodsbin F; Sabetian G; Masjedi M; Tabatabaee HR J Crit Care; 2013 Dec; 28(6):918-22. PubMed ID: 24011845 [TBL] [Abstract][Full Text] [Related]
16. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication. Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660 [TBL] [Abstract][Full Text] [Related]
17. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study. Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397 [TBL] [Abstract][Full Text] [Related]
18. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Skrobik Y; Ahern S; Leblanc M; Marquis F; Awissi DK; Kavanagh BP Anesth Analg; 2010 Aug; 111(2):451-63. PubMed ID: 20375300 [TBL] [Abstract][Full Text] [Related]
19. Awake or Sedated: Trends in the Evaluation and Management of Agitation in the Intensive Care Unit. DeBiasi EM; Akgün KM; Pisani M Semin Respir Crit Care Med; 2015 Dec; 36(6):899-913. PubMed ID: 26595050 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid for agitation in dementia. Lonergan ET; Cameron M; Luxenberg J Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]